0001209191-20-021345.txt : 20200326
0001209191-20-021345.hdr.sgml : 20200326
20200326191750
ACCESSION NUMBER: 0001209191-20-021345
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200324
FILED AS OF DATE: 20200326
DATE AS OF CHANGE: 20200326
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zack Debra
CENTRAL INDEX KEY: 0001807743
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39049
FILM NUMBER: 20747509
MAIL ADDRESS:
STREET 1: C/O EXAGEN, INC.
STREET 2: 1261 LIBERTY WAY, SUITE C
CITY: VISTA
STATE: CA
ZIP: 92081
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EXAGEN INC.
CENTRAL INDEX KEY: 0001274737
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1261 LIBERTY WAY
CITY: VISTA
STATE: CA
ZIP: 92081
BUSINESS PHONE: (760) 560-1501
MAIL ADDRESS:
STREET 1: 1261 LIBERTY WAY
CITY: VISTA
STATE: CA
ZIP: 92081
FORMER COMPANY:
FORMER CONFORMED NAME: EXAGEN DIAGNOSTICS INC
DATE OF NAME CHANGE: 20031230
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-03-24
0
0001274737
EXAGEN INC.
XGN
0001807743
Zack Debra
C/O EXAGEN INC.
1261 LIBERTY WAY, SUITE C
VISA
CA
92081
0
1
0
0
Chief Medical Officer
Stock Option (Right to Buy)
13.44
2020-03-24
4
A
0
100000
0.00
A
2030-03-23
Common Stock
100000
100000
D
The option is exercisable as it vests. 25% of the shares subject to the option vest on March 24, 2021, and 1/48th of the total number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date
/s/ Kamal Adawi, as attorney-in-fact
2020-03-26